{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T07:45:41Z","timestamp":1724485541955},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurg"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00104-016-0259-1","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T05:26:50Z","timestamp":1469510810000},"page":"956-963","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Selektive interne Radioembolisation beim nichtresektablen hepatozellul\u00e4ren Karzinom"],"prefix":"10.1007","volume":"87","author":[{"given":"A.","family":"Bauschke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Altendorf-Hofmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Freesmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Winkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Malessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-H.","family":"Schierz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Teichgraeber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Settmacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"issue":"9","key":"259_CR1","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4251\/wjgo.v2.i9.348","volume":"2","author":"L Rossi","year":"2010","unstructured":"Rossi L, Zoratto F, Papa A, Iodice F, Minozzi M, Frati L, Tomao S (2010) Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2(9):348\u2013359. doi: 10.4251\/wjgo.v2.i9.348","journal-title":"World J Gastrointest Oncol"},{"issue":"4","key":"259_CR2","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"JM Llovet","year":"2012","unstructured":"Llovet JM, Lencioni R, Di Bisceglie AM, Gaile PR, Dufour JF, Greten TF, Raymond E, Roskams T, De Baere T, Ducreux M, Mazzaferro V, Bernardi M, Bruix J, Colombo M, Zhu A (2012) EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol 56(4):908\u2013943","journal-title":"J. Hepatol."},{"issue":"7","key":"259_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3238\/arztebl.2014.0101","volume":"111","author":"NP Malek","year":"2014","unstructured":"Malek NP, Schmidt S, Huber P, Manns MP, Greten TF (2014) The diagnosis and treatment of hepatocellular carcinoma. Dtsch Arztebl Int 111(7):101\u2013106. doi: 10.3238\/arztebl.2014.0101","journal-title":"Dtsch Arztebl Int"},{"issue":"1","key":"259_CR4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","volume":"30","author":"A Forner","year":"2010","unstructured":"Forner A, Reig ME, de Lope CR, Bruix J (2010) Current strategy for staging and treatment: The BCLC update and future prospects. Semin Liver Dis 30(1):61\u201374. doi: 10.1055\/s-0030-1247133","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"259_CR5","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.semradonc.2011.05.004","volume":"21","author":"K Memon","year":"2011","unstructured":"Memon K, Lewandowski RJ, Kulik L, Riaz A, Mulcahy MF, Salem R (2011) Radioembolization for primary and metastatic liver cancer. Semin Radiat Oncol 21(4):294\u2013302. doi: 10.1016\/j.semradonc.2011.05.004","journal-title":"Semin Radiat Oncol"},{"issue":"5 Suppl 1","key":"259_CR6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2004.09.034","volume":"127","author":"JF Geschwind","year":"2004","unstructured":"Geschwind JF, Salem R, Carr BI, Soulen MC, Thurston KG, Goin KA, Van Buskirk M, Roberts CA, Goin JE (2004) Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology 127(5 Suppl 1):194\u2013205","journal-title":"Gastroenterology"},{"issue":"2 Pt 1","key":"259_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.RVI.0000142592.89564.F9","volume":"16","author":"JE Goin","year":"2005","unstructured":"Goin JE, Salem R, Carr BI, Dancey JE, Soulen MC, Geschwind JF, Goin K, Van Buskirk M, Thurston K (2005) Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: Factors associated with liver toxicities. J\u00a0Vasc Interv Radiol 16(2 Pt 1):205\u2013213. doi: 10.1097\/01.RVI.0000142592.89564.F9","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"259_CR8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-0031-1280674","volume":"28","author":"N Hamoui","year":"2011","unstructured":"Hamoui N, Ryu RK (2011) Hepatic radioembolization complicated by fulminant hepatic failure. Semin Intervent Radiol 28(2):246\u2013251. doi: 10.1055\/s-0031-1280674","journal-title":"Semin Intervent Radiol"},{"issue":"7","key":"259_CR9","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jso.20609","volume":"94","author":"LM Kulik","year":"2006","unstructured":"Kulik LM, Atassi B, van Holsbeeck L, Souman T, Lewandowski RJ, Mulcahy MF, Hunter RD, Nemcek AA Jr., Abecassis MM, Haines KG 3rd, Salem R (2006) Yttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: Downstaging to resection, RFA and bridge to transplantation. J Surg Oncol 94(7):572\u2013586. doi: 10.1002\/jso.20609","journal-title":"J Surg Oncol"},{"issue":"6","key":"259_CR10","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1111\/liv.12750","volume":"35","author":"FT Kolligs","year":"2015","unstructured":"Kolligs FT, Bilbao JI, Jakobs T, Inarrairaegui M, Nagel JM, Rodriguez M, Haug A, D\u2019Avola D, op den Winkel M, Martinez-Cuesta A, Trumm C, Benito A, Tatsch K, Zech CJ, Hoffmann RT, Sangro B (2015) Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma. Liver Int 35(6):1715\u20131721. doi: 10.1111\/liv.12750","journal-title":"Liver Int"},{"issue":"2","key":"259_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","volume":"140","author":"R Salem","year":"2011","unstructured":"Salem R, Lewandowski RJ, Kulik L, Wang E, Riaz A, Ryu RK, Sato KT, Gupta R, Nikolaidis P, Miller FH, Yaghmai V, Ibrahim SM, Senthilnathan S, Baker T, Gates VL, Atassi B, Newman S, Memon K, Chen R, Vogelzang RL, Nemcek AA, Resnick SA, Chrisman HB, Carr J, Omary RA, Abecassis M, Benson AB 3rd, Mulcahy MF (2011) Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 140(2):497\u2013507.e492. doi: 10.1053\/j.gastro.2010.10.049","journal-title":"Gastroenterology"},{"issue":"7","key":"259_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ejso.2012.02.189","volume":"38","author":"M Inarrairaegui","year":"2012","unstructured":"Inarrairaegui M, Pardo F, Bilbao JI, Rotellar F, Benito A, D\u2019Avola D, Herrero JI, Rodriguez M, Marti P, Zozaya G, Dominguez I, Quiroga J, Sangro B (2012) Response to radioembolization with yttrium-90 resin microspheres may allow surgical treatment with curative intent and prolonged survival in previously unresectable hepatocellular carcinoma. Eur J Surg Oncol 38(7):594\u2013601. doi: 10.1016\/j.ejso.2012.02.189","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"259_CR13","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/hep.21980","volume":"47","author":"LM Kulik","year":"2008","unstructured":"Kulik LM, Carr BI, Mulcahy MF, Lewandowski RJ, Atassi B, Ryu RK, Sato KT, Benson A 3rd, Nemcek AA Jr., Gates VL, Abecassis M, Omary RA, Salem R (2008) Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis. Hepatology 47(1):71\u201381. doi: 10.1002\/hep.21980","journal-title":"Hepatology"},{"issue":"3","key":"259_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jamcollsurg.2008.12.009","volume":"208","author":"CE Woodall","year":"2009","unstructured":"Woodall CE, Scoggins CR, Ellis SF, Tatum CM, Hahl MJ, Ravindra KV, McMasters KM, Martin RC 2nd (2009) Is selective internal radioembolization safe and effective for patients with inoperable hepatocellular carcinoma and venous thrombosis? J\u00a0Am Coll Surg 208(3):375\u2013382. doi: 10.1016\/j.jamcollsurg.2008.12.009","journal-title":"J. Am. Coll. Surg."},{"issue":"4","key":"259_CR15","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3978\/j.issn.2304-3881.2014.07.09","volume":"3","author":"WH She","year":"2014","unstructured":"She WH, Cheung TT, Yau TC, Chan AC, Chok KS, Chu FS, Liu RK, Poon RT, Chan SC, Fan ST, Lo CM (2014) Survival analysis of transarterial radioembolization with yttrium-90 for hepatocellular carcinoma patients with HBV infection. Hepatobiliary Surg Nutr 3(4):185\u2013193. doi: 10.3978\/j.issn.2304-3881.2014.07.09","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"8","key":"259_CR16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.jvir.2010.04.012","volume":"21","author":"M Inarrairaegui","year":"2010","unstructured":"Inarrairaegui M, Thurston KG, Bilbao JI, D\u2019Avola D, Rodriguez M, Arbizu J, Martinez-Cuesta A, Sangro B (2010) Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis. J Vasc Interv Radiol 21(8):1205\u20131212. doi: 10.1016\/j.jvir.2010.04.012","journal-title":"J Vasc Interv Radiol"},{"issue":"5","key":"259_CR17","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1002\/hep.23944","volume":"52","author":"P Hilgard","year":"2010","unstructured":"Hilgard P, Hamami M, Fouly AE, Scherag A, Muller S, Ertle J, Heusner T, Cicinnati VR, Paul A, Bockisch A, Gerken G, Antoch G (2010) Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival. Hepatology 52(5):1741\u20131749. doi: 10.1002\/hep.23944","journal-title":"Hepatology"},{"issue":"9","key":"259_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1432-2277.2009.00882.x","volume":"22","author":"C Toso","year":"2009","unstructured":"Toso C, Kneteman NM, Shapiro JAM, Bigam DL (2009) The estimated number of patients with hepatocellular carcinoma selected for liver transplantation using expanded selection criteria. Transpl Int 22(9):869\u2013875. doi: 10.1111\/j.1432-2277.2009.00882.x","journal-title":"Transpl Int"},{"issue":"3","key":"259_CR19","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s00270-012-0481-2","volume":"36","author":"LE Moreno-Luna","year":"2013","unstructured":"Moreno-Luna LE, Yang JD, Sanchez W, Paz-Fumagalli R, Harnois DM, Mettler TA, Gansen DN, de Groen PC, Lazaridis KN, Narayanan Menon KV, Larusso NF, Alberts SR, Gores GJ, Fleming CJ, Slettedahl SW, Harmsen WS, Therneau TM, Wiseman GA, Andrews JC, Roberts LR (2013) Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma. Cardiovasc Intervent Radiol 36(3):714\u2013723. doi: 10.1007\/s00270-012-0481-2","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"12","key":"259_CR20","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1016\/j.ijsu.2014.07.269","volume":"12","author":"A Saxena","year":"2014","unstructured":"Saxena A, Meteling B, Kapoor J, Golani S, Danta M, Morris DL, Bester L (2014) Yttrium-90 radioembolization is a safe and effective treatment for unresectable hepatocellular carcinoma: A single centre experience of 45 consecutive patients. Int J Surg 12(12):1403\u20131408. doi: 10.1016\/j.ijsu.2014.07.269","journal-title":"Int J Surg"},{"issue":"5","key":"259_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1002\/cncr.24884","volume":"116","author":"BI Carr","year":"2010","unstructured":"Carr BI, Kondragunta V, Buch SC, Branch RA (2010) Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study. Cancer 116(5):1305\u20131314. doi: 10.1002\/cncr.24884","journal-title":"Cancer"},{"issue":"5","key":"259_CR22","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/j.jhep.2011.11.020","volume":"56","author":"K Memon","year":"2012","unstructured":"Memon K, Kulik L, Lewandowski RJ, Wang E, Ryu RK, Riaz A, Nikolaidis P, Miller FH, Yaghmai V, Baker T, Abecassis M, Benson AB 3rd, Mulcahy MF, Omary RA, Salem R (2012) Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: A subgroup analysis. J Hepatol 56(5):1112\u20131120. doi: 10.1016\/j.jhep.2011.11.020","journal-title":"J. Hepatol."},{"issue":"4","key":"259_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/hep.22747","volume":"49","author":"A Riaz","year":"2009","unstructured":"Riaz A, Kulik L, Lewandowski RJ, Ryu RK, Giakoumis Spear G, Mulcahy MF, Abecassis M, Baker T, Gates V, Nayar R, Miller FH, Sato KT, Omary RA, Salem R (2009) Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology 49(4):1185\u20131193. doi: 10.1002\/hep.22747","journal-title":"Hepatology"},{"issue":"8","key":"259_CR24","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","volume":"9","author":"RJ Lewandowski","year":"2009","unstructured":"Lewandowski RJ, Kulik LM, Riaz A, Senthilnathan S, Mulcahy MF, Ryu RK, Ibrahim SM, Sato KT, Baker T, Miller FH, Omary R, Abecassis M, Salem R (2009) A comparative analysis of transarterial downstaging for hepatocellular carcinoma: Chemoembolization versus radioembolization. Am J Transplant 9(8):1920\u20131928. doi: 10.1111\/j.1600-6143.2009.02695.x","journal-title":"Am J Transplant"},{"issue":"2 Suppl 1","key":"259_CR25","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/lt.20036","volume":"10","author":"BI Carr","year":"2004","unstructured":"Carr BI (2004) Hepatic arterial 90Yttrium glass microspheres (Therasphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients. Liver Transplant 10(2 Suppl 1):107\u2013110. doi: 10.1002\/lt.20036","journal-title":"Liver Transplant"},{"issue":"35","key":"259_CR26","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3748\/wjg.v12.i35.5729","volume":"12","author":"L Rivera","year":"2006","unstructured":"Rivera L, Giap H, Miller W, Fisher J, Hillebrand DJ, Marsh C, Schaffer RL (2006) Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report. World J Gastroenterol 12(35):5729\u20135732","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"259_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1159\/000327577","volume":"29","author":"M Kudo","year":"2011","unstructured":"Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O, Kojiro M, Makuuchi M (2011) Management of hepatocellular carcinoma in Japan: Consensus-Based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29(3):339\u2013364. doi: 10.1159\/000327577","journal-title":"Dig Dis"},{"issue":"7","key":"259_CR28","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","volume":"146","author":"T Yau","year":"2014","unstructured":"Yau T, Tang VY, Yao TJ, Fan ST, Lo CM, Poon RT (2014) Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology 146(7):1691\u20131700.e1693. doi: 10.1053\/j.gastro.2014.02.032","journal-title":"Gastroenterology"},{"issue":"1","key":"259_CR29","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000367728","volume":"4","author":"RT Poon","year":"2015","unstructured":"Poon RT, Cheung TT, Kwok PC, Lee AS, Li TW, Loke KL, Chan SL, Cheung MT, Lai TW, Cheung CC, Cheung FY, Loo CK, But YK, Hsu SJ, Yu SC, Yau T (2015) Hong Kong consensus recommendations on the management of hepatocellular carcinoma. Liver Cancer 4(1):51\u201369. doi: 10.1159\/000367728","journal-title":"Liver Cancer"},{"issue":"Suppl 5","key":"259_CR30","doi-asserted-by":"publisher","first-page":"v59","DOI":"10.1093\/annonc\/mdq166","volume":"21","author":"S Jelic","year":"2010","unstructured":"Jelic S, Sotiropoulos GC (2010) Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 21(Suppl 5):v59\u2013v64. doi: 10.1093\/annonc\/mdq166","journal-title":"Ann Oncol"}],"container-title":["Der Chirurg"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-016-0259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00104-016-0259-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-016-0259-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:10:25Z","timestamp":1498317025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00104-016-0259-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["259"],"URL":"https:\/\/doi.org\/10.1007\/s00104-016-0259-1","relation":{},"ISSN":["0009-4722","1433-0385"],"issn-type":[{"value":"0009-4722","type":"print"},{"value":"1433-0385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}